ENG  Vol.9 No.5 , May 2017
Optimization of Evidence Analysis Cost Using Arbitrary Re-Sampling Techniques for Sample Influx into Forensic Science Laboratory
Abstract: This study analyzes the sample influx (samples per case file) into forensic science laboratory (FSL) and the corresponding analysis costs and uses arbitrary re-sampling plans to establish the minimum cost function. The demand for forensic analysis increased for all disciplines, especially biology/DNA between 2014 and 2015. While the average distribution of case files was about 42.5%, 40.6% and 17% for the three disciplines, the distribution of samples was rather different being 12%, 82.5% and 5.5% for samples requiring forensic biology, chemistry and toxicology analysis, respectively. Results show that most of the analysis workload was on forensic chemistry analysis. The cost of analysis for case files and the corresponding sample influx varied in the ratio of 35:6:1 and 28:12:1 for forensic chemistry, biology/DNA and toxicology for year 2014 for 2015, respectively. In the two consecutive years, the cost for forensic chemistry analysis was comparatively very high, necessitating re-sampling. The time series of sample influx in all disciplines are strongly stochastic, with higher magnitude for chemistry, biology/DNA and toxicology, in this order. The PDFs of sample influx data are highly skewed to the right, especially forensic toxicology and biology/DNA with peaks at 1 and 3 samples per case file. The arbitrary re-sampling plans were best suited to forensic chemistry case files (where re-sampling conditions apply). The locus of arbitrary number of samples to take from the submitted forensic samples was used to establish the minimum and scientifically acceptable samples by applying minimization function developed in this paper. The cost minimization function was also developed based on the average cost per sample and choice of re-sampling plans depending on the range of sample influx, from which the savings were determined and maximized. Thus, the study gives a forensic scientist a business model and scientific decision making tool on minimum number of samples to analyze focusing on savings on analysis cost.
Cite this paper: Manyele, S. (2017) Optimization of Evidence Analysis Cost Using Arbitrary Re-Sampling Techniques for Sample Influx into Forensic Science Laboratory. Engineering, 9, 457-481. doi: 10.4236/eng.2017.95027.

[1]   UDoJ (2010) Review of the Federal Bureau of Investigation Laboratory’s Forensic DNA Case Backlog. U.S. Department of Justice, Office of the Inspector General, Report 10-39.

[2]   Hummel, E., Slowinski, G. Mathews, S. and Gilmont, E. (2010) Business Model for Collaborative Research. Research Technology Management, 53, 51-54.

[3]   Al-Debei, M.M. and Avison, D. (2010) Developing a Unified Framework of the Business Model Concept. European Journal of Information Systems, 19, 359-376.

[4]   Chen, T.F. (2009) Building a Platform Business Model 2.0 to Creating Real Business Value with Web 2.0 for Web Information Services Industry. International Journal of Electronic Business Management, 7, 168-180.

[5]   UNODC (2009) Guidelines on Represented Drug Sampling Laboratory and Research Section of UNODC. United Nations Office of Drugs Control, Vienna.

[6]   Lovrich, N.P., Gaffney, M.J., Pratt, T.C., Johnson, C.L., Asplen, C.H., Hurst, L.H. and Schellberg, T.M. (2004) National Forensic DNA Study Report: Final Report. Washington State University, Division of Governmental Studies and Services, Pullman, Washington DC, Document 203970.

[7]   Bashinski, J. (2010) DNA Laboratory Monthly Statistics. Sacramento, California, Office of the Attorney General, California Department of Justice, Sacramento.

[8]   Hurst, L. and Lothridge, K. (2010) DNA Evidence and Offender Analysis Measurement: DNA Backlogs, Capacity and Funding. U.S. Department of Justice, Washington DC, 230328.

[9]   Wickenheiser, R. (2013) Forensic Laboratory Efficiency and Funding. In: Encyclopedia of Forensic Sciences, 2nd Edition, Elsevier B.V., Amsterdam, 344-350.

[10]   Peterson, J.L. and Hickman, M.J. (2005) Census of Publicly Funded Forensic Crime Laboratories, 2002. Bureau of Justice Statistics Bulletin, NCJ 207205.

[11]   Nelson, M. (2011) Making Some of DNA Backlog in 2010-Myths vs, Reality. Special Report, US-Department of Justice, National Institute of Justice (NIJ).

[12]   Osterwalder, A., Pigneur, Y. and Tucci, C.L. (2005) Clarifying Business Models: Origins, Present, and Future of the Concept. Communications of the Association for Information Systems, 16, 1-40.

[13]   ASTM (2007) Standard Guide for Sampling Seized Drugs to Quantitative and Quantitative Analysis. ASTM International, E2548, PA, USA.

[14]   Frank, R.S., Hinkley, S.W. and Hoffman, C.G. (1991) Representative Sampling of Drug Seizures in Multiple Containers. Journal of Forensic Sciences, 36, 350-357.

[15]   Pratt, T.C., Gaffney, M.J., Lovrich, N.P. and Johnson, C.L. (2006) This Isn’t CSI: Estimating the National Backlog of Forensic DNA Cases and the Barriers Associated with Case Processing. Criminal Justice Policy Review, 17, 32-47.

[16]   CDOJ (2009) An Examination of Forensic Science in California. California Department of Justice, Bureau of Forensic Services. California Crime Laboratory Review Task Force. Sacramento.

[17]   Strom, K.J. and Hickman, M.J. (2010) Unanalyzed Evidence in Law-Enforcement Agencies: A National Examination of Forensic Processing in Police Departments. Criminology and Public Policy, 9, 381-404.

[18]   Colon, M., Rodriguez, G. and Diaz, R.O. (1993) Representative Sampling of “Street” Drug Exhibits. Journal of Forensic Sciences, 38, 641-648.

[19]   Coulson, S.A., Coxon, A. and Backleton, J.S. (2001) How Many Samples from a Drug Seizure Need to Be Analyzed? Journal of Forensic Sciences, 46, 1456-1461.

[20]   Wang, J.F. (2016) Rapid Detection of Human Follicular Tissues at the Crime Scene: A Portable and Digital Solution to Current Backlog of Rape Kits. Journal of Forensic Medicine, 1, e101.

[21]   Slywotzky, A.J. (1996) Value Migration: How to Think Several Moves Ahead of the Competition. Harvard Business Review Press, Boston, MA.